Bronchiolitis Obliterans Clinical Trial
Official title:
A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung Transplantation
This is a single-center pilot study to investigate the efficacy and safety of aerosolized liposomal cyclosporine A in the treatment of chronic rejection in lung transplant recipients with bronchiolitis obliterans syndrome (BOS). The primary objective is to evaluate the efficacy of liposomal cyclosporine A in the treatment of chronic rejection. Pulmonary function and changes in BOS grade are the primary end points.
This is a randomized single-center pilot study to investigate the efficacy and safety of aerosolized liposomal cyclosporine A (L-CsA) in the treatment of chronic rejection in lung transplant recipients with Grade 1 or 2 BOS. The primary endpoints will include: - Improvement or stabilization of pulmonary function test (FEV1) from baseline - Stabilization of histology (no deterioration from baseline) - Safety of the preparation The secondary endpoints will include: - Pharmacokinetics and distribution of CsA in blood - - Change in cytokine levels from BAL specimens. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03603899 -
Hp129 Xenon Imaging and BOS in Lung Transplantation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04098445 -
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
|
||
| Completed |
NCT02441413 -
Transplant Optimization Using Functional Imaging (TROFI)
|
N/A | |
| Recruiting |
NCT02543073 -
MSC for Treatment of Interstitial Lung Disease After Allo-HSCT
|
Phase 1/Phase 2 | |
| Terminated |
NCT01432080 -
Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
|
Phase 2 | |
| Recruiting |
NCT00163696 -
Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease
|
N/A | |
| Completed |
NCT00029328 -
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
|
Phase 1/Phase 2 | |
| Terminated |
NCT01163786 -
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
|
Phase 2 | |
| Recruiting |
NCT02627833 -
Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO
|
N/A | |
| Completed |
NCT01212406 -
Vitamin D in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
| Completed |
NCT01211509 -
Montelukast in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
| Completed |
NCT00701922 -
Surveillance Study of Viral Infections Following Lung Transplantation
|
N/A | |
| Completed |
NCT00141726 -
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
|
Phase 2 | |
| Recruiting |
NCT05922761 -
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
|
Phase 2 | |
| Recruiting |
NCT05881538 -
High Intensity Intervallic Training in Children With Bronchiolitis Obliterans
|
N/A | |
| Terminated |
NCT04655508 -
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
|
Phase 3 | |
| Withdrawn |
NCT02109237 -
Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3
|
N/A | |
| Completed |
NCT01327248 -
Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans
|
N/A | |
| Recruiting |
NCT05932316 -
Evaluating Bronchodilator Response in Patients With Bronchiectasis
|
N/A | |
| Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 |